These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18525183)

  • 21. Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review.
    Zhong JH; Ma L; Wu LC; Zhao W; Yuan WP; Wu FX; Zhang ZM; Huang S; You XM; Li LQ
    Int J Clin Pract; 2012 Jan; 66(1):21-7. PubMed ID: 22171902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis.
    Xu J; Li J; Chen J; Liu ZJ
    Adv Clin Exp Med; 2015; 24(2):331-40. PubMed ID: 25931368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A systematic review and meta-analysis of randomized controlled trails : adjuvant interferon therapy for hepatocellular carcinoma].
    Zhuang LP; Zeng XT; Meng ZQ
    Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):363-7. PubMed ID: 22971282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumoral neoadjuvant immunotherapy using IL-12 and dendritic cells is an effective strategy to control recurrence of murine hepatocellular carcinoma in immunosuppressed mice.
    Kayashima H; Toshima T; Okano S; Taketomi A; Harada N; Yamashita Y; Tomita Y; Shirabe K; Maehara Y
    J Immunol; 2010 Jul; 185(1):698-708. PubMed ID: 20498356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can a vitamin prevent hepatocellular carcinoma?
    Venook AP
    Hepatology; 1997 Jan; 25(1):249-50. PubMed ID: 8985300
    [No Abstract]   [Full Text] [Related]  

  • 26. Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection?
    Clavien PA
    Ann Surg; 2007 Jun; 245(6):843-5. PubMed ID: 17522507
    [No Abstract]   [Full Text] [Related]  

  • 27. Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function.
    Takami T; Yamasaki T; Saeki I; Matsumoto T; Suehiro Y; Sakaida I
    World J Gastroenterol; 2016 Aug; 22(32):7252-63. PubMed ID: 27621572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [HCC: Adoptive immunotherapy promises success].
    Krome S
    Dtsch Med Wochenschr; 2001 Feb; 126(6):A107-8. PubMed ID: 11233890
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatocellular carcinoma: the search for innovative adjuvant therapies.
    Yen Y; Zhou W
    Oncology (Williston Park); 2009 Dec; 23(14):1291, 1294. PubMed ID: 20120843
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemotherapy and medical treatment of hepatocellular carcinoma (HCC).
    Rougier P; Mitry E; Clavero-Fabri MC
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1264-6. PubMed ID: 9730386
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pre- and/or postoperative adjuvant therapy for hepatocellular carcinoma].
    Imaoka S; Sasaki Y
    Nihon Geka Gakkai Zasshi; 1998 Apr; 99(4):229-33. PubMed ID: 9642691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re: Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection?
    Sun HC; Zhang W
    Ann Surg; 2008 May; 247(5):900; author reply 900-1. PubMed ID: 18438131
    [No Abstract]   [Full Text] [Related]  

  • 33. Adjuvant therapy after curative treatment for hepatocellular carcinoma.
    Kudo M
    Oncology; 2011; 81 Suppl 1():50-5. PubMed ID: 22212936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can tertiary prevention of hepatocellular carcinoma be achieved by nucleos(t)ide analogs therapy of hepatitis B?
    Chien RN
    J Gastroenterol Hepatol; 2011 Dec; 26(12):1699-701. PubMed ID: 22097937
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatocellular carcinoma and vitamin K.
    Mizuta T; Ozaki I
    Vitam Horm; 2008; 78():435-42. PubMed ID: 18374204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)].
    Yoshida H; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):463-6. PubMed ID: 15359842
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatocellular carcinoma and adjuvant intra-arterial [131I]Lipiodol.
    Launois B; Maddern G
    Br J Surg; 2002 Nov; 89(11):1345-6. PubMed ID: 12390371
    [No Abstract]   [Full Text] [Related]  

  • 38. Interferon and hepatocellular carcinoma.
    Koretz RL
    Lancet; 1996 Jan; 347(8995):194-5. PubMed ID: 8544565
    [No Abstract]   [Full Text] [Related]  

  • 39. The suppressive effect of nucleos(t)ide analogue treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients.
    Hiramatsu N; Yamada R; Takehara T
    J Gastroenterol Hepatol; 2016 Mar; 31(3):546-52. PubMed ID: 26574149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of hepatocellular carcinoma and its recurrence in chronic hepatitis C patients by interferon therapy.
    Omata M; Yoshida H; Shiratori Y
    Clin Gastroenterol Hepatol; 2005 Oct; 3(10 Suppl 2):S141-3. PubMed ID: 16234063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.